Wellstar International Inc. Announces Improved Beta Test
18 May 2010

Wellstar International Inc. (OTCBB:WLSI) started their second Beta Test in a Long Term Care Facility.
By implementing its second TMI Imaging system, they can help in not only diagnosing but predicting deep tissue injuries.
TMI anticipates in excess of revenues that could exceed more than 1 million dollars per month from this segment of the marketplace.

When analyzing the charts, we can see that WLSI stocks keep good positions on the market. Recently their stocks have gone up to 0.0006 (+85.71%).
The company expects more earnings as major markets, such as University Research Centers, rehabilitation centers, etc. support the need for this type of screening modality.
TMI views this as one of the last steps to be able to implement its system in the LTAC market.

Wellstar International, Inc. works in the health care sector. The company promotes innovative methods for diagnosing and monitoring severe deceases. Their new TMI Infrared Technology and software is approved by the United States Food and Drug Administration (FDA).

Despite the company’s successful projections, the actual results may be completely different. Customers should be aware that any occurrence of unanticipated events or factor changes may reflect on future actions on the market.

No comments
Leave a comment

*
To prove you're a person (not a spam script), type the security word shown in the picture. Click on the picture to hear an audio file of the word.
Click to hear an audio file of the anti-spam word